Spelling suggestions: "subject:"tumor necrosis"" "subject:"humor necrosis""
221 |
The Effects of a Novel Inhibitor of Tumor Necrosis Factor (TNF) Alpha on Prepulse Inhibition and Microglial Activation in Two Distinct Rodent Models of SchizophreniaShelton, Heath W., Gabbita, S. P., Gill, W. D., Burgess, Katherine C., Whicker, Wyatt S., Brown, Russell W. 21 May 2021 (has links)
Increased neuroinflammation has been shown in individuals diagnosed with schizophrenia (SCHZ). This study evaluated a novel immune modulator (PD2024) that targets the pro-inflammatory cytokine tumor necrosis factor-alpha (TNFα) to alleviate sensorimotor gating deficits and microglial activation employing two different rodent models of SCHZ. In Experiment 1, rats were neonatally treated with saline or the dopamine D2-like agonist quinpirole (NQ; 1 mg/kg) from postnatal day (P) 1-21 which produces increases of dopamine D2 receptor sensitivity throughout the animal's lifetime. In Experiment 2, rats were neonatally treated with saline or the immune system stimulant polyinosinic:polycytidylic acid (Poly I:C) from P5-7. Neonatal Poly I:C treatment mimics immune system activation associated with SCHZ. In both experiments, rats were raised to P30 and administered a control diet or a novel TNFα inhibitor PD2024 (10 mg/kg) in the diet from P30 until P67. At P45-46 and from P60-67, animals were behaviorally tested on auditory sensorimotor gating as measured through prepulse inhibition (PPI). NQ or Poly I:C treatment resulted in PPI deficits, and PD2024 treatment alleviated PPI deficits in both models. Results also revealed that increased hippocampal and prefrontal cortex microglial activation produced by neonatal Poly I:C was significantly reduced to control levels by PD2024. In addition, a separate group of animals neonatally treated with saline or Poly I:C from P5-7 demonstrated increased TNFα protein levels in the hippocampus but not prefrontal cortex, verifying increased TNFα in the brain produced by Poly I:C. Results from this study suggests that that brain TNFα is a viable pharmacological target to treat the neuroinflammation known to be associated with SCHZ.
|
222 |
MOLECULAR MECHANISMS OF SYNERGISTIC TRANSCRIPTIONAL REGULATION OF INDOLEAMINE 2,3-DIOXYGENASERobinson, Cory Michael 02 August 2004 (has links)
No description available.
|
223 |
Vitamin D3 and Suppressor of Cytokine Signaling Proteins Reduces Pro-Inflammatory Cytokines in an Alzheimer’s Disease Like-Model Consisting of Microglial and Neuronal Co-CulturesEvdokiou, Alexander 01 August 2017 (has links)
No description available.
|
224 |
Inflammatory Pathways Linking Type 2 Diabetes Mellitus and DepressionDoyle, Todd A. 11 September 2012 (has links)
No description available.
|
225 |
Investigations into the role of proinflammatory cytokines in the pathogenesis of gastric epithelial proliferation in chronic helicobacter pylori gastritisPeterson, Richard A., II January 2003 (has links)
No description available.
|
226 |
Childhood Maltreatment is Associated with Adult Depression: Is Inflammation to Blame?Lewis, Jasmine 12 December 2022 (has links)
By 2030 major depression is predicted to be the leading cause of disease burden in the world; as such, it is critical to understand factors that contribute to the development of depression. The social signal transduction theory of depression hypothesizes that adversity and social threat upregulate pro-inflammatory biomarkers leading to depression. The current study examined whether pro-inflammatory biomarkers (interleukin-6, interleukin-8, c-reactive protein, and tumor necrosis factor alpha) mediate the association between various types of childhood maltreatment (physical abuse, sexual abuse, emotional abuse, physical neglect, emotional neglect) and adult depression symptoms in a sample of 740 adults (372 female; Mage= 51.6 years, SD = 13.6) who provided retrospective report of childhood maltreatment as part of the Midlife in the United States (MIDUS) Refresher Biomarker study. Additionally, it explored whether these relations differ for males versus females. A series of linear regression analyses were run in SPSS; separate models were run for each form of childhood maltreatment and for interleukin-6, interleukin-8, c-reactive protein, and tumor necrosis factor-alpha. The results showed that childhood maltreatment is a robust predictor of adulthood depression; however, this association did not differ between biological sexes. In addition, only interleukin-6 was shown to partially mediate the association between childhood maltreatment and adulthood depression. These findings highlight the need to explore the use of interleukin-6 to screen for depression in youth. / M.S. / By 2030 major depression is predicted to be the leading cause of disease burden in the world; as such, it is critical to understand factors that contribute to the development of depression. It has been hypothesized that adversity and social threat activate pro-inflammatory biomarkers, which are proteins that can detect inflammation in the body, leading to depression. The current study examined whether several pro-inflammatory biomarkers explain the association between several types of childhood maltreatment (physical abuse, sexual abuse, emotional abuse, physical neglect, emotional neglect) and adult depression symptoms in a sample of 740 adults (372 female; Mage= 51.6 years, SD = 13.6) who provided report of past experiences of childhood maltreatment. Additionally, it explored whether these relations differ for males versus females. The results showed that childhood maltreatment is a robust predictor of adulthood depression for males and females. Of the inflammatory biomarkers examined, only interleukin-6 was shown to partially explain the association between childhood maltreatment and adulthood depression symptoms. These findings highlight the need to explore the use of interleukin-6 to screen for depression in youth.
|
227 |
Expression and function of drug transporters in an in vitro model of the mammary epithelial barrier (BME-UV)Al-Bataineh, Mohammad M. January 1900 (has links)
Doctor of Philosophy / Department of Diagnostic Medicine/Pathobiology / Ronette Gehring / Milk composition has a dynamic nature, and the composition varies with stage of lactation, age, breed, nutrition and health status of the udder. The changes in milk composition seem to match the changes in the expression of membrane proteins in secretory mammary epithelial cells that are needed for the movement of molecules from blood to milk and vice versa (Nouws and Ziv, 1982). Thus, an understanding of transporter expression, function and regulation in mammary epithelial cells can provide insight into mammary gland function and regulation.
The goal of this project was to elucidate (molecularly and functionally) the role of drug transporters in the barrier function of an epithelial monolayer cultured from an immortalized bovine mammary epithelial cell line (BME-UV). To characterize the regulation (expression and function) of these drug transporters in BME-UV cells after exposure to cytokine TNF-α for selected periods of time. Representative members of drug transporters of the SLC (OCT and OAT) and ABC (P-glycoprotein) superfamilies were chosen for this project.
In the first study, the involvement of a carrier-mediated transport system in the passage of organic cation (TEA) and anion (EsS) compounds was elucidated across the BME-UV monolayer. In the second study, molecular and functional expression of bOAT isoforms in BME-UV cells were studied. The final study characterized the effects of cytokine TNF-α on the expression and function of P-glycoprotein, an efflux pump, in BME-UV cells. Cytokine TNF-α exposure induced the expression of ABCB1 mRNA and increased P-glycoprotein production in BME-UV cells, resulting in a greater efflux of digoxin, a known P-glycoprotein substrate, back into the apical fluid.
The expression, function, and regulation of these transporters in the mammary gland has important implications for understanding the barrier function of the mammary epithelium and, in more specific, for characterizing the role of these transporters in the accumulation and/or removal of specific substrates from milk and/or plasma. Moreover, this study provides an in vitro cell culture model of mammary epithelium to characterize mammary epithelial cell function during inflammation.
|
228 |
Signalling mechanisms involved in TNF-α mediated cytoprotection during ischaemic injury in a C2C12 muscle cell lineLoos, Benjamin January 1900 (has links)
Thesis (MSc)--University of Stellenbosch, 2006. / ENGLISH ABSTRACT: Both, the cytokine Tumor Necrosis Factor-α (TNF-α) and the enzyme cytosolic
phospholipase A2 (cPLA2) are crucial driving forces in mediating the cellular
inflammatory response and are involved in ischaemic injury. During an ischaemic
insult, TNF-α is endogenously generated. Apart from the recognized effects of TNF-
α, such as the induction of apoptosis, proliferation and differentiation, if present in
low dosages, it also mediates cytoprotective effects. Upon activation, cPLA2
contributes to the ischaemic challenge with the generation of mediators of cellular
injury and apoptosis. Upon stimulation, this calcium dependent enzyme translocates
to the phospholipid compartment of the cell membrane and induces the hydrolysis of
sn-2 ester bonds in phospholipids. It governs the release of free fatty acids and
lysophospholipids and generates role players of inflammation. We suggest a role for
cPLA2 in the TNF-α mediated cytoprotection, with a distinct phosphorylation and
translocation pattern.
Aims
The involvement of cPLA2 in TNF-α mediated cytoprotection in the C2C12 murine
skeletal muscle cell line in tolerance to ischaemia was examined. To investigate the
nature of the cPLA2 phosphorylation pattern, the mitogen activated protein kinases
(MAPKs) p38 and extracellular regulated kinase (ERK) as contributors to cPLA2
phosphorylation and activation, were examined at appropriate time points. To dissect
out the cPLA2 interplay and dependencies with these MAPKs within the pathway
context, the selective cPLA2 inhibitor arachidonyl trifluoromethyl ketone (AACOCF3)
was employed and its effect on cell viability was examined. Fluorescence microscopy
was used to substantiate cPLA2 activation, by assessing its cellular distribution,
translocation and cell organelle target preference, using co-localization and z-stack
techniques. In addition, the induction of the apoptotic pathway through analysis of
caspase-3 and poly (ADP-ribose) polymerase (PARP) cleavage was examined. The
role of caspase-3 in cPLA2 turnover was addressed employing the caspase inhibitor,
Z-DEVD-FMK. Methods
Cells were grown in Dulbecco’s Modified Eagles Medium (DMEM) with 10% fetal
bovine serum (FBS), and incubated under 5% CO2 conditions, until 50%-70%
confluent. Using DMEM supplemented with 1% horse serum, cell differentiation into
myotubes was induced. Differentiated cells were preconditioned for 30 min
classically, with 0.5 ng/ml TNF-α or the cPLA2 selective inhibitor AACOCF3 (10
μM) respectively. Followed by a 60 min washout period the cells were subjected to 8
hrs simulated ischaemia. Cellular viability; and cPLA2 phosphorylation- and
translocation events were assessed using Western blots and advanced
immunocytochemistry and imaging techniques.
Results
Preconditioning with TNF-α, ischaemic preconditioning; and the use of the cPLA2
inhibitor AACOCF3, attenuated the decrease is cell viability brough about by
ischaemia. Western blot analysis indicates the induction of the apoptotic pathway with
caspase-3 and PARP cleavage. A significantly reduced translocation of pcPLA2 to the
nuclear region in the TNF-α preconditioned group compared to the ischaemic group,
as reflected by reduced mean nuclear fluorescence intensity, was observed. A z-stack
analysis confirmed that the nuclear and endonuclear region was the target organelle
for cPLA2. 3-dimensional co-localazation analysis of pcPLA2 with the nuclear marker
nucleoporin p62 mirrored these results.
Discussion and conclusion
Our results provide evidence that there is a role for cPLA2 in TNF-α mediated
cytoprotection. Although we do not observe a differential activation pattern in terms
of cPLA2 phosphorylation at various time points within the ischaemic event, and no
differential inactivation of cPLA2 via caspase-mediated cPLA2 cleavage, we describe
a differential cPLA2 translocation pattern, similar to that in IPC. Through inhibition of
cPLA2 translocation, a functional cPLA2 inhibition might be achieved. This would
imply inhibition of the inflammatory pathway and a subsequent reduction in the
generation of inflammatory mediators. In addition we describe an effect of TNF-α
preconditioning on the efficacy of the caspase inhibitor Z-DEVD-FMK. Our results shed light on the survival mechanisms employed by the ischaemically challenged cell
in a setting of TNF-α mediated cytoprotection. This might lead to novel approaches in
the context of inflammation treatment, through agents that control differential cPLA2
trafficking within the cell. / AFRIKAANSE OPSOMMING: Beide, die sitokien “Tumor Necrosis Factor-α (TNF-α)” en die ensiem, sitosoliese
fosfolipase A2 (cPLA2) is uiters belangrike bemiddelaars van die sellulêre
inflammatoriese respons en is verder ook betrokke by isgemiese selskade. TNF-α
word endogeen gegenereer tydens ‘n isgemiese intervensie. Afgesien van ‘n
verskeidenheid effekte, soos die inisiëring van apoptose, sel-proliferasie en -
differensiasie, bemiddel dit ook selbeskermende meganismes indien dit in lae
konsentrasies in die sel teenwoordig is. Na aktivering dra cPLA2 by tot die isgemiese
intervensie deur die vorming van bemiddelaars van selskade en apoptose. Hierdie
kalsium-afhanklike ensiem translokeer na die fosfolipied membraankomponent na
stimulering en induseer die hidrolise van die sn-2 esterbinding in die fosfolipied. Die
vrystelling van vry vetsure en lisofosfolipiede word sodoende bewerkstellig wat
verder gemetaboliseer kan word tot inflammatoriese bemiddelaars. Ons stel voor dat
cPLA2 ‘n rol in TNF-α bemiddelde selbeskerming speel en dat dit gepaardgaan met
kenmerkende fosforilerings- en translokeringspatrone.
Doelwitte
Die rol van cPLA2 tydens TNF-α bemiddelde selbeskerming is in ‘n C2C12
skeletspiersellyn na blootstelling aan isgemie ondersoek. Die rol van die MAPKs, p38
en ERK, is ondersoek om vas te stel of hulle betrokke is by die aktivering van cPLA2.
Die selektiewe cPLA2 inhibitor, AACOCF3, is gebruik om te bepaal of die
fosforilering van MAPKs ook cPLA2-afhanklik is. Die sellulêre cPLA2 verspreiding,
translokering en teiken selorganelle is ook ondersoek met behulp van fluoresensie
mikroskopie deur gebruik te maak van ko-lokalisering en z-plaat tegnieke. Verder, is
die indusering van die apoptotiese paaie ondersoek deur tegnieke wat kaspase- en
PARP kliewing meet. Die kaspase inhibitor, Z-DEVD-FMK, is gebruik om vas te stel
of kaspase-3 ‘n rol speel in cPLA2 kliewing in ons selmodel.
Metodes
Selle is gekweek in Dulbecco’s gemodifiseerde Eagles Medium (DMEM) waarby
10% fetale kalf serum (FBS) gevoeg is, en wat geïnkubeer is in 5% CO2 totdat dit
50%-70% konfluent was. Die selle is verder gedifferensieer in miobuise deur gebruik te maak van DMEM waarby 1% perdeserum gevoeg is. Gedifferensieerde selle is vir
30 min klassiek geprekondisioneer asook respektiewelik met 0.5 ng/ml TNF-α en die
cPLA2 selektiewe inhibitor, AACOCF3 (10 μM). Na ‘n 60 minute uitwas periode is
die selle blootgestel aan 8 h gesimuleerde isgemie. Sellulêre lewensvatbaarheid,
cPLA2 fosforilering- and translokering is ondersoek deur onderskeidelik gebruik te
maak van die “Western” klad metode en gesofistikeerde immunositochemiese beeld
tegnieke.
Resultate
Prekondisionering met TNF-α, isgemiese prekondisionering asook inhibisie van as
cPLA2 met die inhibitor, AACOCF3, het ‘n beduidende toename in
sellewensvatbaarheid tot gevolg gehad. Daar is ook dmv die “Western” klad tegniek
bewys dat apoptose geïduseer word deur middel van kaspase-3- en PARP kliewing.
Daar is insiggewend minder translokasie van cPLA2 na die nukluêre fraksie in die
isgemiese groep in vergelyking met die TNF-α geprekondisioneerde groep
waargeneem (die gemiddelde nukluêre fluoreserende intensiteit is bepaal om
voorafgaande feit te staaf). Die cPLA2 teiken organel is geverifieer as die nukleus en
die endonukluêre gebied deur middel van z-plaat analises. Drie-dimensionele kolokaliserings
analises van pcPLA2 met die nukluêre merker, nucleoporin p62 het
hierdie resultate bevestig.
Bespreking en Gevolgtrekking
Ons resultate verskaf bewyse vir ‘n rol vir cPLA2 in TNF-α bemiddelde
selbeskerming. Alhoewel daar nie ‘n differensiële aktiveringspatroon in terme van
cPLA2 fosforilering tydens verskeie tydspunte in die isgemiese intervensie
waargeneem is nie, en ook geen kaspase-3 bemiddelde kliewing van cPLA2 nie, word
‘n differensiële translokeringspatroon soorgelyk aan die isgemiese
prekondisioneringsgroep, waargeneem. Funsksionele cPLA2 inhibisie kan dus
moontlik bewerkstellig word deur inhibisie van cPLA2 translokasie. Die
inflammatoriese respons kan dus moontlik so inhibieer word en die vorming van
minder inflammatoriese bemiddelaars tot gevolg hê. Verder het TNF-α
prekondisionering ook ‘n effek op die effektiwiteit van die kaspase-inhibitor, ZDEVD-
FMK. Ons resultate werp ook lig op die meganismes wat deur selle onder isgemiese toestande uitgeoefen word tydens TNF-α bemiddelde selbeskerming.
Hierdie resultate mag lei tot nuwe benaderings in die konteks van behandeling teen
inflammasie deur gebruik te maak van middels wat cPLA2 translokering in die sel
beheer.
|
229 |
An investigation into the P13-K/AKT signalling pathway in TNF-a-induced muscle proeolysis in L6 myotubesSishi, Balindiwe J. N. 12 1900 (has links)
Thesis (MSc (Physiological Sciences))--Stellenbosch University, 2008. / Introduction: Skeletal muscle atrophy is a mitigating complication that is characterized by
a reduction in muscle fibre cross-sectional area as well as protein content, reduced force,
elevated fatigability and insulin resistance. It seems to be a highly ordered and regulated
process and signs of this condition are often seen in inflammatory conditions such as cancer,
AIDS, diabetes and chronic heart failure (CHF). It has long been understood that an
imbalance between protein degradation (increase) and protein synthesis (decrease) both
contribute to the overall loss of muscle protein. Although the triggers that cause atrophy are
different, the loss of muscle mass in each case involves a common phenomenon that induces
muscle proteolysis. It is becoming evident that interactions among known proteolytic systems
(ubiquitin-proteosome) are actively involved in muscle proteolysis during atrophy. Factors
such as TNF-α and ROS are elevated in a wide variety of chronic inflammatory diseases in
which skeletal muscle proteolysis presents a lethal threat. There is an increasing body of
evidence that implies TNF-α may play a critical role in skeletal muscle atrophy in a number of
clinical settings but the mechanisms mediating its effects are not completely understood. It is
also now apparent that the transcription factor NF-κB is a key intracellular signal transducer
in muscle catabolic conditions. This study investigated the various proposed signalling
pathways that are modulated by increasing levels of TNF-α in a skeletal muscle cell line, in
order to synthesize our current understanding of the molecular regulation of muscle atrophy.
Materials and Methods: L6 (rat skeletal muscle) cells were cultured under standard
conditions where after reaching ± 60-65% confluency levels, differentiation was induced for a
maximum of 8 days. During the last 2 days, myotubes were incubated with increasing
concentrations of recombinant TNF-α (1, 3, 6 and 10 ng/ml) for a period of 40 minutes, 24
and 48 hours. The effects of TNF-α on proliferation and cell viability were measured by MTT
assay and Trypan Blue exclusion technique. Morphological assessment of cell death was
conducted using the Hoechst 33342 and Propidium Iodide staining method. Detection of
apoptosis was assessed by DNA isolation and fragmentation assay. The HE stain was used for
the measurement of cell size. In order to determine the source and amount of ROS production,
MitoTracker Red CM-H2 X ROS was utilised. Ubiquitin expression was assessed by
immunohistochemistry. PI3-K activity was calculated by using an ELISA assay and the
expression of signalling proteins was analysed by Western Blotting using phospho-specific and total antibodies. Additionally, the antioxidant Oxiprovin was used to investigate the
quantity of ROS production in TNF-α-induced muscle atrophy.
Results and Discussion: Incubation of L6 myotubes with increasing concentrations of
recombinant TNF-α revealed that the lower concentrations of TNF-α used were not toxic to
the cells but data analysis of cell death showed that 10 ng/ml TNF-α induced apoptosis and
necrosis. Long-term treatment with TNF-α resulted in an increase in the upregulation of TNF-
α receptors, specifically TNF-R1. The transcription factors NF-κB and FKHR were rapidly
activated thus resulting in the induction of the ubiquitin-proteosome pathway. Activation of
this pathway produced significant increases in the expression of E3 ubiquitin ligases MuRF-1
and MAFbx. Muscle fibre diameter appeared to have decreased with increasing TNF-α
concentrations in part due to the suppressed activity of the PI3-K/Akt pathway as well as
significant reductions in differentiation markers. Western blot analysis also showed that
certain MAPKs are activated in response to TNF-α. No profound changes were observed with
ROS production. Finally, the use Oxiprovin significantly lowered cell viability and ROS
production. These findings suggest that TNF-α may elicit strong catabolic effects on L6
myotubes in a dose and time dependent manner.
Conclusion: These observations suggest that TNF-α might have beneficial effects in
skeletal muscle in certain circumstances. This beneficial effect however is limited by several
aspects which include the concentration of TNF-α, cell type, time of exposure, culture
conditions, state of the cell (disturbed or normal) and the cells stage of differentiation. The
effect of TNF-α can be positive or negative depending on the concentration and time points
analysed. This action is mediated by various signal transduction pathways that are thought to
cooperate with each other. More understanding of these pathways as well as their subsequent
upstream and downstream constituents is obligatory to clarify the central mechanism/s that
control physiological and pathophysiological effects of TNF-α in skeletal muscle.
|
230 |
Body composition and systematic low-grade inflammation in children : the PLAY study / Rachelle A. PretoriusPretorius, Rachelle Ann January 2006 (has links)
Background: Obesity-related diseases are arising as a major problem among children. inflammation
has recently been identified to play an important role in the relationship between obesity.- as well as
stunting-related diseases.
Objectives: The aim of this study was to assess the association between serum tumour necrosis factor-alpha
(TNF-α), interleukin-6 (IL-6) and C-reactive protein (CRP) concentrations and a variety of
cardiometabolic and anthropometric indices of children in a township outside Potchefstroom, South
Africa.
Methods: Blood samples of 115 girls and 78 boys (mean age 15.6 ± 1.35) in the Physical Activity in
the Young (PLAY) study were cross-sectionally analysed. Trained fieldworkers collected the
demographic, Tanner growth stage and habitual physical activity information. Physiologists measured
the children’s blood pressure. Anthropometric measurements were taken by. trained post-graduate
students with level 1 or 2 qualifications in anthropometrics. A standard test battery was administered
by trained postgraduate students in Human Movement Science to assess muscular strength. flexibility
and endurance of the children. Blood samples were collected, centrifuged and stored frozen until
further analyses.
Results: Stunted girls had a significantly higher serum TNF-α concentration than the non-stunted girls
(p=0.03). The factor analyses showed that the inflammatory. status clustered with the height for age-z-scores
(HAZ) scores and the waist-hip-ratio (WHR). The HAZ-score of the over-fat boys (- 1.46) was
significantly smaller than the lean boys (- 1.14, p=0.0 1). whereas the over-fat girls had a trend for a
smaller HAZ-score (-1.07) than the lean girls (-0.89). No significant differences were found between
the over-fat and the lean children-s inflammatory status. TNF-α and CRP levels tended to be higher in
the over-fat children than in lean children. The girls' scrum IL-6 and CRP concentrations correlated
significantly with their body mass index (BMI) and WHR (p<0.05 )and their TNF-α and IL-6
concentrations correlated significantly with their WHR (p<0.01 and p<0.05, respectively).
Conclusion: In comparison to the non-stunted girls, stunted girls had a statistically significantly higher
TNF-α concentration. Unusual fat distribution that is found in over-fat and stunted children may be
associated with low-grade inflammation in children. More research is needed on these associations with
markers of inflammation in a long-term longitudinal study. / Thesis (M.Sc. (Nutrition))--North-West University, Potchefstroom Campus, 2007.
|
Page generated in 0.0698 seconds